Imasawa Toshiyuki, Murayama Kei, Hirano Daishi, Nozu Kandai
Department of Nephrology, National Hospital Organization Chibahigashi National Hospital, 673 Nitona-cho, Chuoh-ku, Chiba, 206-8712, Japan.
Diagnostics and Therapeutic of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, 2-1-1, Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Clin Exp Nephrol. 2025 Jan;29(1):39-56. doi: 10.1007/s10157-024-02554-y. Epub 2024 Dec 3.
Mitochondrial nephropathy is a genetic renal disease characterized by oxidative phosphorylation abnormalities in the mitochondrial respiratory chain in kidney cells, caused by pathogenic gene variants located on mitochondrial or nuclear DNA. Recent advancements in genetic diagnostic techniques and their widespread adoption have led to the identification of various genes associated with mitochondrial nephropathy. This review investigates the causative genes and clinicopathological features of mitochondrial nephropathy, including the various phenotypes and associated complications, and suggests potential pathogenic mechanisms. Furthermore, the diagnostic methods of the disease are explained with particular emphasis on characteristic pathological findings and genetic analysis. We also analyze the available long-term observational prognostic data. Although there is currently no evidence-based treatment for mitochondrial nephropathy, an overview of the existing treatment options is discussed, including future expectations. The choice of renal replacement therapy in cases with progression to end-stage renal disease has also been discussed. Overall, this review highlights the importance of raising awareness about mitochondrial nephropathy and establishing appropriate diagnostic systems to facilitate rapid and effective treatment.
线粒体肾病是一种遗传性肾脏疾病,其特征是肾细胞线粒体呼吸链中的氧化磷酸化异常,由线粒体或核DNA上的致病基因变异引起。基因诊断技术的最新进展及其广泛应用已导致鉴定出与线粒体肾病相关的各种基因。本综述研究了线粒体肾病的致病基因和临床病理特征,包括各种表型和相关并发症,并提出了潜在的致病机制。此外,还解释了该疾病的诊断方法,特别强调了特征性病理发现和基因分析。我们还分析了现有的长期观察性预后数据。虽然目前尚无基于证据的线粒体肾病治疗方法,但讨论了现有治疗选择的概述,包括未来期望。还讨论了终末期肾病进展病例中肾脏替代治疗的选择。总体而言,本综述强调了提高对线粒体肾病的认识和建立适当诊断系统以促进快速有效治疗的重要性。